62 search results for: coexisting diseases

Master Clinician Video | Advanced Clinical Practice in EoE (Full)
Gastroenterology
Master Clinician Video | Advanced Clinical Practice in EoE (Full)
videoanimation

Learn how a food bolus impaction event can help identify a patient with EoE and the importance of multiple disease domains in assessing EoE.

View more
Patients With Prurigo Nodularis Have a High Prevalence of Atopic and Non-Atopic Comorbidities​
Dermatology
Patients With Prurigo Nodularis Have a High Prevalence of Atopic and Non-Atopic Comorbidities​
expert video

Listen as Dr. Sarina Elmariah explores the comorbidities associated with prurigo nodularis.

View more
Prurigo Nodularis Is a Challenging Diagnosis
Dermatology
Prurigo Nodularis Is a Challenging Diagnosis
expert video

Join Dr. Sarina Elmariah as she discusses the challenges in diagnosing prurigo nodularis.

View more
Charting the Future: Preventing the Atopic March
Dermatology
Charting the Future: Preventing the Atopic March
expert video

In this clip from the April WCPD 2025 symposium, Dr Eulàlia Baselga discusses data identifying atopic dermatitis as the first diagnosed atopic disease and the start of the atopic march.

View more
ADVENT at EADV 2026
On Demand
Stepping Up: Expert Perspectives on CSU From Diagnosis to Disease Control

Drs Martin Metz, Moshe Ben-Shoshan, and Michelle Tarbox shared expert perspectives on chronic spontaneous urticaria (CSU) during an engaging ADVENT symposium at EADV 2026 in Vienna, Austria. The symposium explored key considerations across the CSU patient journey, from diagnosis to disease control. Key topics included the multifaceted burden of CSU on patients, caregivers, and families, practical approaches to diagnosis and assessment of disease control, and considerations for treatment escalation and advanced therapy selection in adult and pediatric patients with CSU.

ADVENT at EADV 2026
On Demand
Atopic Dermatitis at ​an Inflection Point: ​Refining Outcomes Through Timely, Targeted Intervention

Prof. Tilo Biedermann and Drs. Nicole Chase and Lisa Swanson presented an engaging ADVENT educational symposium at EADV 2026 on September 30 in Vienna, Austria, focusing on the local and systemic role of type 2 inflammation in atopic dermatitis (AD) and its implications for disease management across the lifespan. The symposium explored the potential to achieve sustained optimal disease control with systemic therapy in adults, as well as the potential window of opportunity for early intervention to reduce or prevent multidimensional disease burden in pediatric AD.

IL-4 Is the Primary Cytokine That Drives Th2 Cell Polarization and Amplifies Type 2 Inflammation
Type 2 Inflammation
IL-4 Is the Primary Cytokine That Drives Th2 Cell Polarization and Amplifies Type 2 Inflammation
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof Oscar Palomares describes how IL-4 is the key cytokine involved in the initiation and perpetuation of Th2 cell responses and type 2 inflammation.

View more
Type 2 Inflammatory Disease: What Are the Mechanisms that Contribute to the Development of Other Atopic Comorbidities?
Type 2 Inflammation
Type 2 Inflammatory Disease: What Are the Mechanisms that Contribute to the Development of Other Atopic Comorbidities?
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof. Oscar Palomares explains how type 2 inflammation and barrier dysfunction contribute to the development of atopic comorbidities and increased susceptibility to infections.

View more
Type 2 Inflammation Is a Driving Factor for Atopic Dermatitis and Related Comorbidities
Dermatology
Type 2 Inflammation Is a Driving Factor for Atopic Dermatitis and Related Comorbidities
expert video

Dr. Lawrence Eichenfield describes the pathophysiology of atopic dermatitis and how type 2 inflammation may sensitize patients to atopic comorbidities.

View more
Beyond Clinical Control: Targeting Type 2 Inflammation for Improved Patient Outcomes
Dermatology
Beyond Clinical Control: Targeting Type 2 Inflammation for Improved Patient Outcomes
expert video

Prof Alan Irvine presents the latest clinical and real-world evidence supporting the potential for disease modification in atopic dermatitis, at EADV 2025.

View more
Can Therapy-Free Disease Control Be Achieved in Atopic Dermatitis?
Dermatology
Can Therapy-Free Disease Control Be Achieved in Atopic Dermatitis?
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof. Amy Paller reviews a Japanese study showing that early proactive treatment of infant atopic dermatitis with topical corticosteroids reduced the incidence of food allergy but was also associated with decreased gains in height and weight.

View more
Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP
Rhinology
Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP
expert video

In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Vibeke Backer discusses how Type 2 inflammation drives severe, uncontrolled CRSwNP. It covers key immune cells and biomarkers (e.g., IL-4, IL-5, IL-13, TSLP), global prevalence differences, and the importance of symptom tracking and targeted therapies.

View more